Project Grant R01DK143214
- Federal Project Grant Summary The Leland Stanford Junior University received a $782,886 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded February 18, 2026, with a completion date of January 31, 2031. The research project focuses on the control of obesity through an appetite-suppressing peptide, addressing the urgent need for new therapeutic...
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded The Leland Stanford Junior University a Project Grant of $796,068 under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) effective February 1, 2026, through January 31, 2031. This five-year research initiative investigates the role of the beta-hydroxybutyrate (BHB) shunt—a recently discovered third metabolic pathway for BHB—in regulating...
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $724,180 Project Grant to The Leland Stanford Junior University, effective September 1, 2025 through August 31, 2030, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The research focuses on facilitating islet implantation and engraftment following transplantation through the application of primed umbilical cord mesenchymal stem...
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded The Leland Stanford Junior University a $2.74 million Project Grant on September 5, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The four-year project, extending through September 4, 2029, supports basic biomedical research investigating the genetic variation underlying innate lymphoid cell (ILC) phenotypes and their...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded The Leland Stanford Junior University a $1.5M project grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to characterize pretransplant operations across U.S. adult kidney transplant programs and identify strategies to improve transplant access and reduce care costs. Awarded on September 15, 2025, with completion targeted for August 31,...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded The Leland Stanford Junior University a Project Grant of $392,459 under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to develop and evaluate a social media counter-marketing campaign designed to improve diet quality among young adults ages 18-29. The research addresses the critical public health challenge that unhealthy diet quality...
- Federal Grant Award Summary Boston Children's Hospital received a $3.1 million Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded September 3, 2025, with a completion date of September 2, 2029. This four-year research project investigates the role of lipogenic (fat-generating) pathways in intestinal remodeling following Roux-en-Y gastric bypass (RYGB)...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded Stanford University a $534,802 Project Grant on February 5, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The research, scheduled for completion by November 30, 2029, focuses on understanding the role of T-cell oligoclonality in benign prostatic hyperplasia (BPH) pathogenesis. Stanford researchers will conduct basic immunological...
- Federal Project Grant Award Summary The University of Southern California received a $845,922 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded March 1, 2026, with a completion date of January 31, 2031. The research investigates the role of gut-brain pathways in childhood obesity and youth-onset Type 2 Diabetes development through a longitudinal...
- Federal Project Grant Award Summary The University of California, San Francisco received a $2.97 million Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded September 4, 2025, with completion targeted for August 31, 2029. This award supports translational research investigating the regulatory mechanisms of fatty acids (FAs) in cellular metabolism and...
The Leland Stanford Junior University received a $681,391 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective March 12, 2026, with completion scheduled for February 28, 2030. This research grant funds a clinical investigation into rapid gastric emptying as a modifiable risk factor for postbariatric hypoglycemia (PBH), a serious complication affecting up to 38% of bariatric surgery patients that causes multiple daily hypoglycemic episodes potentially resulting in seizures, loss of consciousness, and death. The primary deliverable is rigorous clinical research testing three potential therapeutic interventions known to slow gastric emptying in non-surgical populations, with the aim of translating these treatments to the unique physiologic context of post-bariatric surgery patients. The study will evaluate dietary modification (adding fat prior to standardized meals), pharmaceutical intervention (GLP1 agonist semaglutide), and additional treatment modalities, with outcomes measured through standardized mixed meal tolerance testing to assess effects on gastric emptying rates and glucose nadir levels. These clinically available interventions could provide immediate treatment options for PBH patients with Roux-en-Y gastric bypass and vertical sleeve gastrectomy procedures, addressing a critical gap in therapeutic options for this patient population.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $681.4k | 3/12/26 |